Evidence map›Paper›PMID 26679472›Full record

ArticleShock (Augusta, Ga.)2016

TLR2 Regulates Complement-Mediated Inflammation Induced by Blood Loss During Hemorrhage.

Jeremy Goering, Michael R Pope, Sherry D Fleming

Open access · greenAbstract read
In one paragraph

Article in Shock (Augusta, Ga.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Hemorrhagic shock induces renal complement activation.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2021
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jeremy GoeringDivision of Biology, Kansas State University, Manhattan, Kansas.
Michael R Pope
Sherry D Fleming
Kansas State University · US

Funding

Mentoring CoreP20GM103418 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Douglas E Wright · 2012 to 2026
$63.0M
Natural Antibodies and Tissue InjuryR01AI061691 · NIAID · KANSAS STATE UNIVERSITY · PI FLEMING, SHERRY · 2007 to 2011
$1.7M
Neoantigens and TLR4R21AI107005 · NIAID · KANSAS STATE UNIVERSITY · PI FLEMING, SHERRY · 2014 to 2015
$413k
NIAID NIH HHS R01 AI061691NIAID NIH HHS R21 AI107005NIGMS NIH HHS P20 GM103418NIGMS NIH HHS P20GM103418
6 · The paper itself

Abstract

Hemorrhagic shock resulting from blood loss directs the majority of the blood to the vital organs, dramatically reducing blood flow to the intestines and resulting in damage and inflammation. The excessive intestinal inflammatory response includes pro-inflammatory cytokines and complement activation, although the mechanism is not clear. Toll-like receptors play a vital role in the innate immune response and toll-like receptor 2 (TLR2) is required for intestinal ischemia/reperfusion-induced injury. We hypothesized that TLR2 plays an integral role in the intestinal inflammatory response after hemorrhage and subjected C57Bl/6 wild-type and Tlr2(-/-) mice to atraumatic loss of ∼30% total blood volume. Two hours after blood removal, the intestinal injury and inflammation were assessed. We demonstrate that compared with wild-type control mice, Tlr2(-/-) mice sustain less intestinal damage and inflammation. Importantly, TLR2 regulated eicosanoid and complement activation and IL-12 and TNFα secretions, indicating interactions between TLR2 and complement in response to significant blood loss.

Indexed as

AnimalsComplement ActivationComplement System ProteinsInflammationInflammation MediatorsIntestinesMaleMice, Inbred C57BLMice, KnockoutRegional Blood FlowShock, HemorrhagicToll-Like Receptor 2Complement System ProteinsInflammation MediatorsToll-Like Receptor 2

Identifiers

PMID26679472
PMCPMC4685733
OpenAlexW2331837500

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.